Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
32 hedge funds and large institutions have $225M invested in Forward Pharma A/S American Depositary Shares in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
45% more funds holding
Funds holding: 22 → 32 (+10)
44% more capital invested
Capital invested by funds: $156M → $225M (+$68.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
+$12.7M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.73M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
+$5.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.08M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$2.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$12M |
| 2 |
GCM
Gruss Capital Management
New York
|
-$1.93M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.89M |
| 4 |
SH
Sandia Holdings
Greenwich,
Connecticut
|
-$1.48M |
| 5 |
MFWM
Motley Fool Wealth Management
Alexandria,
Virginia
|
-$1.08M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Envestnet Asset Management
Chicago,
Illinois
| $8K | +$188 | +1 | +2% |
|
|
FPF
27
FNY Partners Fund
New York
| $8K | +$10.7K | +57 | New |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $6K | +$8.1K | +43 | New |
|
29
UBS Group
Zurich,
Switzerland
| $4K | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $3K | +$2.64K | +14 | New |
|
31
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
O
32
OrbiMed
New York
| – | -$12M | -114,000 | Closed |
|
|
GCM
33
Gruss Capital Management
New York
| – | -$1.93M | -18,329 | Closed |
|
|
MFWM
34
Motley Fool Wealth Management
Alexandria,
Virginia
| – | -$1.08M | -10,334 | Closed |
|
FWP Hedge Fund Activity: Q1 2017 in Review
32 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2017, worth a combined $225M — up 44% from $156M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new FWP positions and 3 closed out — a net gain of 10 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Senzar Asset Management, opening a new position worth an estimated $12.7M. The largest seller was OrbiMed, exiting entirely with an estimated $12M sold.
- 32 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2017, up from 22 in Q4 2016.
- Funds reported $225M of Forward Pharma A/S American Depositary Shares stock for Q1 2017, up 44% quarter-over-quarter.
- 13 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2017 and 3 closed out, a net change of +10 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q1 2017 was Senzar Asset Management, an estimated $12.7M added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2017 was OrbiMed, an estimated $12M sold.
Based on aggregated 13F filings for Q1 2017.